These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28445304)

  • 121. A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma.
    Purdue MP; Lan Q; Wang SS; Kricker A; Menashe I; Zheng TZ; Hartge P; Grulich AE; Zhang Y; Morton LM; Vajdic CM; Holford TR; Severson RK; Leaderer BP; Cerhan JR; Yeager M; Cozen W; Jacobs K; Davis S; Rothman N; Chanock SJ; Chatterjee N; Armstrong BK
    Carcinogenesis; 2009 Feb; 30(2):275-81. PubMed ID: 19029192
    [TBL] [Abstract][Full Text] [Related]  

  • 122. The pro-inflammatory environment in recalcitrant diabetic foot wounds.
    Acosta JB; del Barco DG; Vera DC; Savigne W; Lopez-Saura P; Guillen Nieto G; Schultz GS
    Int Wound J; 2008 Oct; 5(4):530-9. PubMed ID: 19006574
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population.
    Tao K; Fujii M; Tsukumo S; Maekawa Y; Kishihara K; Kimoto Y; Horiuchi T; Hisaeda H; Akira S; Kagami S; Yasutomo K
    Ann Rheum Dis; 2007 Jul; 66(7):905-9. PubMed ID: 17344245
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes.
    Creely SJ; McTernan PG; Kusminski CM; Fisher fM; Da Silva NF; Khanolkar M; Evans M; Harte AL; Kumar S
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E740-7. PubMed ID: 17090751
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse.
    Mohammad MK; Morran M; Slotterbeck B; Leaman DW; Sun Y; Grafenstein Hv; Hong SC; McInerney MF
    Int Immunol; 2006 Jul; 18(7):1101-13. PubMed ID: 16728431
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease.
    Schröder NW; Schumann RR
    Lancet Infect Dis; 2005 Mar; 5(3):156-64. PubMed ID: 15766650
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Association study of Toll-like receptor 9 gene polymorphism in Korean patients with systemic lupus erythematosus.
    Hur JW; Shin HD; Park BL; Kim LH; Kim SY; Bae SC
    Tissue Antigens; 2005 Mar; 65(3):266-70. PubMed ID: 15730519
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation?
    Andreakos E; Foxwell B; Feldmann M
    Immunol Rev; 2004 Dec; 202():250-65. PubMed ID: 15546398
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Toll-like receptor signalling.
    Akira S; Takeda K
    Nat Rev Immunol; 2004 Jul; 4(7):499-511. PubMed ID: 15229469
    [No Abstract]   [Full Text] [Related]  

  • 130. Neuronal injury mediated via stimulation of microglial toll-like receptor-9 (TLR9).
    Iliev AI; Stringaris AK; Nau R; Neumann H
    FASEB J; 2004 Feb; 18(2):412-4. PubMed ID: 14688201
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Regulation of wound healing by growth factors and cytokines.
    Werner S; Grose R
    Physiol Rev; 2003 Jul; 83(3):835-70. PubMed ID: 12843410
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies.
    Lazarus R; Klimecki WT; Raby BA; Vercelli D; Palmer LJ; Kwiatkowski DJ; Silverman EK; Martinez F; Weiss ST
    Genomics; 2003 Jan; 81(1):85-91. PubMed ID: 12573264
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Toll-like receptors: critical proteins linking innate and acquired immunity.
    Akira S; Takeda K; Kaisho T
    Nat Immunol; 2001 Aug; 2(8):675-80. PubMed ID: 11477402
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Differential expression of Toll-like receptor 2 in human cells.
    Flo TH; Halaas O; Torp S; Ryan L; Lien E; Dybdahl B; Sundan A; Espevik T
    J Leukoc Biol; 2001 Mar; 69(3):474-81. PubMed ID: 11261796
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Toll-like receptors-2 and -9 (TLR2 and TLR9) gene polymorphism in patients with type 2 diabetes and diabetic foot.
    Wifi MA; Assem M; Elsherif RH; El-Azab HA; Saif A
    Medicine (Baltimore); 2017 Apr; 96(17):e6760. PubMed ID: 28445304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 7.